Hongchang International Co. Ltd. Insider Trading

HCIL

Last 12 months

Insiders sold 2K and bought nothing on the open market.

None of the selling was scheduled in advance under a 10b5-1 plan. The last open-market buy by an executive or director was in May 2023.

Net open-market

−2K

0 buys · 1 sale

Under a 10b5-1 plan

of the value sold

Insiders who bought / sold

0 / 1

executives and directors

Last open-market buy

May 2023

May 17, 2023

Get an email when HCIL's executives or directors buy, or make a large sale outside a plan.

Trades · last 2 years

Date	Insider	Trade	Shares	Price	Value	Of their stake	Filing
Jun 23 – 25	Zhenzhu Lin Director	SoldNo plan 3 parts	16,448	$0.11 average	2K	<0.1%	Form 4

Jun 23 – 25No plan
Zhenzhu Lin
Director · sold 16,448 at avg $0.11
2K
<0.1% of stake

How to read this. Insiders sell for many reasons: taxes, diversifying, a house. Open-market buys are rarer and say more. A 10b5-1 plan is a trading schedule set up months in advance, so those sales were not timed on news. Large holders (funds and 10% owners) are listed under Everything but not counted as insiders. If you own or watch HCIL, we send a push when an executive buys or makes a large sale outside a plan.

Source: SEC Form 4 filings, filed within two business days of each trade and checked for new ones every hour.

Peers

Electromedical & Electrotherapeutic Apparatus · Pick stocks to compare with HCIL

CompareIntrinsic value

YBGJYubo International Biotech Limited

$0.01+0.00%0

NXLNexalin Technology Inc.

$1.56+1.30%10

ENDVEndonovo Therapeutics Inc.

$0.00+0.00%15

POSCPositron Corporation

$1.67-1.76%0

GTHPGuided Therapeutics Inc.

$0.10-33.33%30

RDGLVivos Inc.

$0.04-1.64%40

PAVMPAVmed Inc.

$1.66-8.79%25

MBOTMicrobot Medical Inc.

$1.14+4.59%25

Spot a number that looks wrong? Check it in HCIL's SEC filings or

Download this analysis as a PDF (Pro)

Data sourced from SEC EDGAR filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.

2 of 2 free stocks used today

Keep analysing HCIL

Create a free account and get 14 days of Premium: every stock and every tool.

Unlimited stocksQuality, fair value and dividends for 10,000+ stocks
Stock screenerFilter on quality, valuation and dividend safety
Portfolio trackerReal return, dividend calendar and portfolio quality
Editable DCFChange the assumptions and watch fair value move
Compare side by sideUp to 10 stocks in one table
Unlimited alertsPrice, P/E, Quality Score and yield

No card. Moves to Free after, unless you upgrade.

Already have an account?

Or come back tomorrow. Stocks on your watchlist are always free to view.